[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Radiologic Cancer Therapy - Market Insights, Competitive Landscape and Market Forecast–2026

April 2021 | 120 pages | ID: R4E775277A07EN
DelveInsight

US$ 4,750.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 7-10 Business Days

DelveInsight’s ‘Radiologic Cancer Therapy - Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Radiologic Cancer Therapy and the historical and forecasted Radiologic Cancer Therapy market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.

The Radiologic Cancer Therapy market report provides an overview of Radiologic Cancer Therapy, applications of Radiologic Cancer Therapy as well as its PEST Analysis. Additionally, the report provides insight on the Radiologic Cancer Therapy market share of the individual Radiologic Cancer Therapy, current and forecasted Radiologic Cancer Therapy market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Radiologic Cancer Therapy Overview

The radiation therapy, also known as the radiotherapy is form of cancer treatment which generally, uses high doses of radiation, for killing cancer cells and shrinking tumors. There are two main types of radiation therapy: external beam and internal beam radiation therapy. The type of therapy that is recommended for an individual depends on a lot of factors including the type of cancer, size of the tumor, location of the tumor, proximity of the normal healthy tissues to that of the tumor, and others.

Study Period: 2018–2026

Geography Covered
  • The US
  • EU5 (Germany, France, Spain, Italy, and the United Kingdom)
  • Japan
List of Companies

Accuray, Inc., Nordion Inc., Varian Medical Systems, IsoRay, Inc., Ion Beam Applications SA, Elekta AB, C.R. Bard, Inc., Mallinckrodt Public Ltd., Mevion Medical Systems among others.

Radiologic Cancer Therapy - Competitive Analysis

This segment of the report provides a brief competitive analysis of Radiologic Cancer Therapy, to help understand the competition in the market. It gives a comparative understanding of the products based on technology.

Radiologic Cancer Therapy: Market Segmentation

By Product Type
  • Electron-Emitting High-Energy Linear Accelerators
  • Compact Advanced Radiotherapy Systems
  • Brachytherapy
  • Systemic Beam Radiation Therapy
  • Others
By Technology
  • Image-Guided Radiotherapy (IGRT)
  • Stereotactic Technology
  • Intensity Modulated Radiotherapy (IMRT)
  • Proton Beam Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Others
Radiologic Cancer Therapy: Market Dynamics

Market Drivers
  • Rising adoption of radiotherapy
  • Technological advancement in radiotherapy
Market Barriers
  • Lower effectiveness of certain radiological therapy devices
  • Alter effects of some radiological therapy devices
Radiologic Cancer Therapy: Market Analysis

This segment illustrates the market of Radiologic Cancer Therapy across the 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.

KOL Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Radiologic Cancer Therapy domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Radiologic Cancer Therapy market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report
  • The report covers the descriptive overview of Radiologic Cancer Therapy, explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Radiologic Cancer Therapy is provided, which will have an impact on the future market of Radiologic Cancer Therapy.
  • A detailed review of Radiologic Cancer Therapy market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the Radiologic Cancer Therapy market.
Report Highlights
  • The report covers descriptive overview of the Radiologic Cancer Therapy, explaining its applications, working mechanism, etc.
  • The report is a comprehensive account of marketed devices present in the Radiologic Cancer Therapy market.
  • The report also reviews the detailed historical and forecasted Radiologic Cancer Therapy market, including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the Radiologic Cancer Therapy market.
Radiologic Cancer Therapy Report Key Strengths
  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • PEST Analysis
  • Market Size
Radiologic Cancer Therapy Report Assessment
  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views
Key Questions

Market Insights:
  • What was the Radiologic Cancer Therapy market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the Radiologic Cancer Therapy total market size as well as market size by devices across the 7MM during the forecast period (2018–2026)?
  • What are the key findings pertaining to the market across the 7MM and which country will have the largest Radiologic Cancer Therapy market size during the forecast period (2018–2026)?
  • At what CAGR, the Radiologic Cancer Therapy market is expected to grow in the 7MM during the forecast period (2018–2026)?
  • What will be the Radiologic Cancer Therapy market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the Radiologic Cancer Therapy market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?
Competitive Landscape:
  • What are the current devices available in the Radiologic Cancer Therapy?
  • What is the Radiologic Cancer Therapy available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Radiologic Cancer Therapy?
  • What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Radiologic Cancer Therapy?
  • What are the key designations that have been granted for the current Radiologic Cancer Therapy?
  • What are the 7MM countries historical and forecasted market of Radiologic Cancer Therapy?
1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF RADIOLOGIC CANCER THERAPY

3. RADIOLOGIC CANCER THERAPY: BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Types of Radiologic Cancer Therapy
3.3. Advantages of Radiologic Cancer Therapy
3.4. Disadvantages of Radiologic Cancer Therapy

4. RADIOLOGIC CANCER THERAPY: REGULATORY SCENARIO

5. RADIOLOGIC CANCER THERAPY: REIMBURSEMENT SCENARIO

6. COMPANY PROFILES

6.1. Accuray, Inc.
  6.1.1. Company Overview
  6.1.2. Product Portfolio
    6.1.2.1. Product description
    6.1.2.2. Regulatory Milestones
    6.1.2.3. Research and Development
    6.1.2.4. Product Development Activities
6.2. Nordion Inc.
  6.2.1. Company Overview
  6.2.2. Product Portfolio
    6.2.2.1. Product description
    6.2.2.2. Regulatory Milestones
    6.2.2.3. Research and Development
    6.2.2.4. Product Development Activities
More Companies in the final report…

7. RADIOLOGIC CANCER THERAPY: COMPETITIVE ANALYSIS

8. KOL VIEWS

9. RADIOLOGIC CANCER THERAPY: MARKET ANALYSIS IN 7MM

9.1. Radiologic Cancer Therapy: Market Analysis in 7MM by Product type (2018–2026)
9.2. Radiologic Cancer Therapy: Market Analysis in 7MM by Technology (2018–2026)

10. COUNTRY-WISE MARKET SIZE OF RADIOLOGIC CANCER THERAPY IN 7MM (2018–2026)

10.1. Market size of Radiologic Cancer Therapy in the United States
  10.1.1. Radiologic Cancer Therapy: Market Analysis in the United State by Product type (2018–2026)
  10.1.2. Radiologic Cancer Therapy: Market Analysis in the United State by Technology (2018–2026)
10.2. Market size of Radiologic Cancer Therapy in Germany
  10.2.1. Radiologic Cancer Therapy: Market Analysis in Germany by Product type (2018–2026)
  10.2.2. Radiologic Cancer Therapy: Market Analysis in Germany by Technology (2018–2026)
10.3. Market size of Radiologic Cancer Therapy in France
  10.3.1. Radiologic Cancer Therapy: Market Analysis in France by Product type (2018–2026)
  10.3.2. Radiologic Cancer Therapy: Market Analysis in France by Technology (2018–2026)
10.4. Market size of Radiologic Cancer Therapy in Spain
  10.4.1. Radiologic Cancer Therapy: Market Analysis in Spain by Product type (2018–2026)
  10.4.2. Radiologic Cancer Therapy: Market Analysis in Spain by Technology (2018–2026)
10.5. Market size of Radiologic Cancer Therapy in Italy
  10.5.1. Radiologic Cancer Therapy: Market Analysis in Italy by Product type (2018–2026)
  10.5.2. Radiologic Cancer Therapy: Market Analysis in Italy by Technology (2018–2026)
10.6. Market size of Radiologic Cancer Therapy in the UK
  10.6.1. Radiologic Cancer Therapy: Market Analysis in the UK by Product type (2018–2026)
  10.6.2. Radiologic Cancer Therapy: Market Analysis in the UK by Technology (2018–2026)
10.7. Market size of Radiologic Cancer Therapy in Japan
  10.7.1. Radiologic Cancer Therapy: Market Analysis in Japan by Product type (2018–2026)
  10.7.2. Radiologic Cancer Therapy: Market Analysis in Japan by Technology (2018–2026)

11. MARKET DYNAMIC

11.1. Market Drivers
11.2. Market Barriers

12. PEST ANALYSIS

13. CONCLUSION AND FUTURE PERSPECTIVE

14. APPENDIX

14.1. Bibliography
14.2. Report Methodology

15. DELVEINSIGHT CAPABILITIES

16. DISCLAIMER

17. ABOUT DELVEINSIGHT

LIST OF TABLES

Table 1: Competitive Analysis
Table 2: Radiologic Cancer Therapy: Market Analysis in the 7MM (2018–2026)
Table 3: Radiologic Cancer Therapy: Market Analysis in the 7MM by Product type (2018–2026)
Table 4: Radiologic Cancer Therapy: Market Analysis in the 7MM by Technology (2018–2026)
Table 5: Radiologic Cancer Therapy: United States Market Analysis (2018–2026)
Table 6: Radiologic Cancer Therapy: Market Analysis in the US by Product type (2018-2026)
Table 7: Radiologic Cancer Therapy: Market Analysis in the US by Technology (2018-2026)
Table 8: Radiologic Cancer Therapy: Germany Market Analysis (2018–2026)
Table 9: Radiologic Cancer Therapy: Market Analysis in Germany by Product type (2018-2026)
Table 10: Radiologic Cancer Therapy: Market Analysis in Germany by Technology (2018-2026)
Table 11: Radiologic Cancer Therapy: France Market Analysis (2018–2026)
Table 12: Radiologic Cancer Therapy: Market Analysis in France by Product type (2018-2026)
Table 13: Radiologic Cancer Therapy: Market Analysis in France by Technology (2018-2026)
Table 14: Radiologic Cancer Therapy: Spain Market Analysis (2018–2026)
Table 15: Radiologic Cancer Therapy: Market Analysis in Spain by Product type (2018-2026)
Table 16: Radiologic Cancer Therapy: Market Analysis in Spain by Technology (2018-2026)
Table 17: Radiologic Cancer Therapy: Italy Market Analysis (2018–2026)
Table 18: Radiologic Cancer Therapy: Market Analysis in Italy by Product type (2018-2026)
Table 19: Radiologic Cancer Therapy: Market Analysis in Italy by Technology (2018-2026)
Table 20: Radiologic Cancer Therapy: United Kingdom Market Analysis (2018–2026)
Table 21: Radiologic Cancer Therapy: Market Analysis in the UK by Product type (2018-2026)
Table 22: Radiologic Cancer Therapy: Market Analysis in the UK by Technology (2018-2026)
Table 23: Radiologic Cancer Therapy: Japan Market Analysis (2018–2026)
Table 24: Radiologic Cancer Therapy: Market Analysis in Japan by Product type (2018-2026)
Table 25: Radiologic Cancer Therapy: Market Analysis in Japan by Technology (2018-2026)


LIST OF FIGURES

Figure 1: Product description of Radiologic Cancer Therapy
Figure 2: Radiologic Cancer Therapy: Market Analysis in the 7MM (2018–2026)
Figure 3: Radiologic Cancer Therapy: Market Analysis in the 7MM by Product type (2018–2026)
Figure 4: Radiologic Cancer Therapy: Market Analysis in the 7MM by Technology (2018–2026)
Figure 5: Radiologic Cancer Therapy: United States Market Analysis (2018–2026)
Figure 6: Radiologic Cancer Therapy: Market Analysis in the US by Product type (2018-2026)
Figure 7: Radiologic Cancer Therapy: Market Analysis in the US by Technology (2018-2026)
Figure 8: Radiologic Cancer Therapy: Germany Market Analysis (2018–2026)
Figure 9: Radiologic Cancer Therapy: Market Analysis in Germany by Product type (2018-2026)
Figure 10: Radiologic Cancer Therapy: Market Analysis in Germany by Technology (2018-2026)
Figure 11: Radiologic Cancer Therapy: France Market Analysis (2018–2026)
Figure 12: Radiologic Cancer Therapy: Market Analysis in France by Product type (2018-2026)
Figure 13: Radiologic Cancer Therapy: Market Analysis in France by Technology (2018-2026)
Figure 14: Radiologic Cancer Therapy: Spain Market Analysis (2018–2026)
Figure 15: Radiologic Cancer Therapy: Market Analysis in Spain by Product type (2018-2026)
Figure 16: Radiologic Cancer Therapy: Market Analysis in Spain by Technology (2018-2026)
Figure 17: Radiologic Cancer Therapy: Italy Market Analysis (2018–2026)
Figure 18: Radiologic Cancer Therapy: Market Analysis in Italy by Product type (2018-2026)
Figure 19: Radiologic Cancer Therapy: Market Analysis in Italy by Technology (2018-2026)
Figure 20: Radiologic Cancer Therapy: United Kingdom Market Analysis (2018–2026)
Figure 21: Radiologic Cancer Therapy: Market Analysis in the UK by Product type (2018-2026)
Figure 22: Radiologic Cancer Therapy: Market Analysis in the UK by Technology (2018-2026)
Figure 23: Radiologic Cancer Therapy: Japan Market Analysis (2018–2026)
Figure 24: Radiologic Cancer Therapy: Market Analysis in Japan by Product type (2018-2026)
Figure 25: Radiologic Cancer Therapy: Market Analysis in Japan by Technology (2018-2026)
Figure 26: Market Drivers
Figure 27: Market Barriers


More Publications